[1] Pandey S, Sharma S. Meige's syndrome:history, epidemiology,clinical features, pathogenesis and treatment[J]. J Neurol Sci, 2017, 372:162-170.
[2] Behari M. Current status of dystonias including Meige's syndrome[J]. Neurol India, 2018, 66:36-37.
[3] Reese R, Volkmann J. Deep brain stimulation for the dystonias:evidence, knowledge gaps, and practical considerations[J]. Mov Disord Clin Pract, 2017, 4:486-494.
[4] Rodrigues FB, Duarte GS, Prescott D, Ferreira J, Costa J. Deep brain stimulation for dystonia[J]. Cochrane Database Syst Rev, 2019, 1:CD012405.
[5] Horisawa S, Ochiai T, Goto S, Nakajima T, Takeda N, Kawamata T, Taira T. Long-term outcome of pallidal stimulation for Meige syndrome[J]. J Neurosurg, 2018, 130:84-89.
[6] Sako W, Morigaki R, Mizobuchi Y, Tsuzuki T, Ima H, Ushio Y, Nagahiro S, Kaji R, Goto S. Bilateral pallidal deep brain stimulation in primary Meige syndrome[J]. Parkinsonism Relat Disord, 2011, 17:123-125.
[7] Zhan S, Sun F, Pan Y, Liu W, Huang P, Cao C, Zhang J, Li D, Sun B. Bilateral deep brain stimulation of the subthalamic nucleus in primary Meige syndrome[J]. J Neurosurg, 2018, 128:897-902.
[8] Yao C, Horn A, Li N, Lu Y, Fu Z, Wang N, Aziz TZ, Wang L, Zhang S. Post-operative electrode location and clinical efficacy of subthalamic nucleus deep brain stimulation in Meige syndrome[J]. Parkinsonism Relat Disord, 2019, 58:40-45.
[9] Wang N, Wang XS, Guo YP, Fu ZH, Chen GQ, Wang L. Deep brain stimulation of bilateral subthalamic nucleus for the treatment of drug-refractory Meige syndrome[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 2019, 35:1006-1010.[王宁, 王晓松,郭宇鹏, 付宗荟, 陈国强, 王林. 双侧丘脑底核脑深部电刺激术治疗药物难治性Meige综合征的疗效[J]. 中华神经外科杂志, 2019, 35:1006-1010.]
[10] Bari AA, Thum J, Babayan D, Lozano AM. Current and expected advances in deep brain stimulation for movement disorders[J]. Prog Neurol Surg, 2018, 33:222-229.
[11] Cernera S, Okun MS, Gunduz A. A review of cognitive outcomes across movement disorder patients undergoing deep brain stimulation[J]. Front Neurol, 2019, 10:419.
[12] Meoni S, Zurowski M, Lozano AM, Hodaie M, Poon YY, Fallis M, Voon V, Moro E. Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia[J]. Neurology, 2015, 85:433-440.
[13] Dinkelbach L, Mueller J, Poewe W, Delazer M, Elben S, Wolters A, Karner E, Wittstock M, Benecke R, Schnitzler A, Volkmann J, Südmeyer M. Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia:one year follow up results of a prospective multicenter trial[J]. Parkinsonism Relat Disord, 2015, 21:976-980.
[14] Neuroophthalmology Group, Ophthalmology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of Meige syndrome in China (2018)[J]. Zhonghua Yan Ke Za Zhi, 2018, 54:93-96.[中华医学会眼科学分会神经眼科学组. 我国Meige综合征诊断和治疗专家共识(2018年)[J]. 中华眼科杂志, 2018, 54:93-96.]
[15] Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A. Dystonia rating scales:critique and recommendations[J]. Mov Disord, 2013, 28:874-883.
[16] Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A; Movement Disorders Society Rating Scales Committee. Measurement instruments to assess posture, gait, and balance in Parkinson's disease:critique and recommendations[J]. Mov Disord, 2016, 31:1342-1355.
[17] Miocinovic S, Somayajula S, Chitnis S, Vitek JL. History, applications, and mechanisms of deep brain stimulation[J]. JAMA Neurol, 2013, 70:163-171.
[18] Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, Matthews K, McIntyre CC, Schlaepfer TE, Schulder M, Temel Y, Volkmann J, Krauss JK. Deep brain stimulation:current challenges and future directions[J]. Nat Rev Neurol, 2019, 15:148-160.
[19] Tian H, Yu Y, Zhen X, Zhang L, Yuan Y, Zhang B, Wang L. Long-term efficacy of deep brain stimulation of bilateral globuspallidus internus in primary Meigesyndrome[J]. Stereotact Funct Neurosurg, 2019, 97(5/6):356-361.
[20] Vijiaratnam N, Wijeratne T. Botulinum toxin in patients with Meige's syndrome[J]. Neurol India, 2018, 66:38-39.
[21] Aires A, Gomes T, Linhares P, Cunha F, Rosas MJ, Vaz R. The impact of deep brain stimulation on health related quality of life and disease-specific disability in Meige Syndrome (MS)[J]. Clin Neurol Neurosurg, 2018, 171:53-57.
[22] Baizabal-Carvallo JF, Jankovic J. Movement disorders induced by deep brain stimulation[J]. Parkinsonism Relat Disord, 2016, 25:1-9.
[23] Bouthour W, Béreau M, Kibleur A, Zacharia A, Tomkova Chaoui E, Fleury V, Benis D, Momjian S, Bally J, Lüscher C, Krack P, Burkhard PR. Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease[J]. Mov Disord, 2019, 34:1728-1734.
[24] Mei S, Eisinger RS, Hu W, Tsuboi T, Foote KD, Hass CJ, Okun MS, Chan P, Ramirez-Zamora A. Three-year gait and axial outcomes of bilateral STN and GPi Parkinson's disease deep brain stimulation[J]. Front Hum Neurosci, 2020, 14:1.
[25] Zheng Z, Li Y, Li J, Zhang Y, Zhang X, Zhuang P. Stimulation-induced dyskinesia in the early stage after subthalamic deep brain stimulation[J]. Stereotact Funct Neurosurg, 2010, 88:29-34.
[26] Sriram A, Foote KD, Oyama G, Kwak J, Zeilman PR, Okun MS. Brittle dyskinesia following STN but not GPi deep brain stimulation[J]. Tremor Other Hyperkinet Mov (NY), 2014, 4:242. |